MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: MMS_Medical_Surgical Training & Simulation
Osso VR
Industry: Silicon Valley, California
Kronos Bio, Inc. (NASDAQ: KRON)*
Organization & Developments: Kronos Bio
Parents
Kronos Bio, Inc. (NASDAQ: KRON)*
Children
*Kronos Bio, Inc., is a private clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics through a precision medicine strategy by targeting dysregulated transcription
*The company is developing the CDK9 inhibitor KB-0742 as a treatment for MYC-dependent solid tumors and other transcriptionally addicted solid tumors and lanraplenib, a next-generation SYK inhibitor, for patients with FLT3-mutated acute myeloid leukemia.
2023: Kronos Bio Announces Plan to Optimize Resource Allocation, Restructure and Contain Costs Following Positive Preliminary Clinical Data from its KB-0742 Phase 1/2 Study
2024: Kronos to lay off 83% of workforce, change CEOs after mothballing lone clinical asset
Jumps
Finance & Acquisitions: Kronos Bio
Key People: Kronos Bio